chr16-51141732-T-TGCCGCC

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP3BS1_SupportingBS2

The NM_002968.3(SALL1):​c.484_489dupGGCGGC​(p.Gly162_Gly163dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000428 in 1,610,726 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000027 ( 0 hom. )

Consequence

SALL1
NM_002968.3 conservative_inframe_insertion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter U:1B:1

Conservation

PhyloP100: 2.36

Publications

0 publications found
Variant links:
Genes affected
SALL1 (HGNC:10524): (spalt like transcription factor 1) The protein encoded by this gene is a zinc finger transcriptional repressor and may be part of the NuRD histone deacetylase complex (HDAC). Defects in this gene are a cause of Townes-Brocks syndrome (TBS) as well as bronchio-oto-renal syndrome (BOR). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SALL1 Gene-Disease associations (from GenCC):
  • Townes-Brocks syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Townes-Brocks syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_002968.3
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000199 (30/150964) while in subpopulation EAS AF = 0.000582 (3/5156). AF 95% confidence interval is 0.000326. There are 0 homozygotes in GnomAd4. There are 17 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 30 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002968.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SALL1
NM_002968.3
MANE Select
c.484_489dupGGCGGCp.Gly162_Gly163dup
conservative_inframe_insertion
Exon 2 of 3NP_002959.2
SALL1
NM_001127892.2
c.193_198dupGGCGGCp.Gly65_Gly66dup
conservative_inframe_insertion
Exon 2 of 3NP_001121364.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SALL1
ENST00000251020.9
TSL:1 MANE Select
c.484_489dupGGCGGCp.Gly162_Gly163dup
conservative_inframe_insertion
Exon 2 of 3ENSP00000251020.4
SALL1
ENST00000566102.1
TSL:1
c.77-4186_77-4181dupGGCGGC
intron
N/AENSP00000455582.1
SALL1
ENST00000440970.6
TSL:5
c.484_489dupGGCGGCp.Gly162_Gly163dup
conservative_inframe_insertion
Exon 3 of 4ENSP00000407914.2

Frequencies

GnomAD3 genomes
AF:
0.000199
AC:
30
AN:
150846
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000494
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000394
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000580
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000603
AC:
15
AN:
248582
AF XY:
0.0000668
show subpopulations
Gnomad AFR exome
AF:
0.000510
Gnomad AMR exome
AF:
0.0000580
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000218
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.0000267
AC:
39
AN:
1459762
Hom.:
0
Cov.:
53
AF XY:
0.0000248
AC XY:
18
AN XY:
726184
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000270
AC:
9
AN:
33390
American (AMR)
AF:
0.000112
AC:
5
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.000479
AC:
19
AN:
39688
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86064
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53274
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5438
European-Non Finnish (NFE)
AF:
0.00000360
AC:
4
AN:
1110818
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60260
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.381
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000199
AC:
30
AN:
150964
Hom.:
0
Cov.:
32
AF XY:
0.000230
AC XY:
17
AN XY:
73810
show subpopulations
African (AFR)
AF:
0.000492
AC:
20
AN:
40644
American (AMR)
AF:
0.000394
AC:
6
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3454
East Asian (EAS)
AF:
0.000582
AC:
3
AN:
5156
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4748
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10580
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67840
Other (OTH)
AF:
0.00
AC:
0
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Townes syndrome Uncertain:1
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant, c.484_489dup, results in the insertion of 2 amino acid(s) of the SALL1 protein (p.Gly162_Gly163dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs779674923, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with SALL1-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

SALL1-related disorder Benign:1
Aug 30, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.4
Mutation Taster
=74/26
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1555475414; hg19: chr16-51175643; API